open access

Vol 90, No 4 (2019)
ORIGINAL PAPERS Obstetrics
Published online: 2019-04-29
Get Citation

Prognosis and related risk factors of patients with scarred uterus complicated with central placenta previa

Juntao Zheng, Shanshan Liu, Jianqin Xing
DOI: 10.5603/GP.2019.0033
·
Pubmed: 31059110
·
Ginekol Pol 2019;90(4):185-188.

open access

Vol 90, No 4 (2019)
ORIGINAL PAPERS Obstetrics
Published online: 2019-04-29

Abstract

Objectives: To analyze the prognosis and related risk factors of patients with scarred uterus complicated with central placenta previa. 

Material and methods: A total of 272 parturient women admitted to our hospital between June 2013 and December 2016 were selected, of whom 142 cases with central placenta previa were designated as a control group and another 130 with scarred uterus complicated with central placenta previa were allocated as an observation group. The delivery outcomes of the two groups were compared, and the influencing factors were comprehensively analyzed. 

Results: The prenatal and postpartum blood losses of the observation group were significantly higher than those of the control group (P < 0.05). The incidence rates of placental adhesion, placenta accreta, hysterectomy and puerperal infection in the obstetric group significantly exceeded those of the control group (P < 0.05). Logistic regression analysis showed that postpartum hemorrhage and placenta implantation were risk factors affecting prognosis (P < 0.05). 

Conclusions: Patients with scarred uterus and central placenta previa suffered from serious complications such as profuse postpartum hemorrhage and placental adhesion after delivery. Particular attention should be paid to women with scarred uterus during subsequent pregnancy to prevent placenta previa and to reduce the risks of delivery, thereby benefiting prognosis evaluation. 

Abstract

Objectives: To analyze the prognosis and related risk factors of patients with scarred uterus complicated with central placenta previa. 

Material and methods: A total of 272 parturient women admitted to our hospital between June 2013 and December 2016 were selected, of whom 142 cases with central placenta previa were designated as a control group and another 130 with scarred uterus complicated with central placenta previa were allocated as an observation group. The delivery outcomes of the two groups were compared, and the influencing factors were comprehensively analyzed. 

Results: The prenatal and postpartum blood losses of the observation group were significantly higher than those of the control group (P < 0.05). The incidence rates of placental adhesion, placenta accreta, hysterectomy and puerperal infection in the obstetric group significantly exceeded those of the control group (P < 0.05). Logistic regression analysis showed that postpartum hemorrhage and placenta implantation were risk factors affecting prognosis (P < 0.05). 

Conclusions: Patients with scarred uterus and central placenta previa suffered from serious complications such as profuse postpartum hemorrhage and placental adhesion after delivery. Particular attention should be paid to women with scarred uterus during subsequent pregnancy to prevent placenta previa and to reduce the risks of delivery, thereby benefiting prognosis evaluation. 

Get Citation

Keywords

scarred uterus; central placenta previa; risk factor

About this article
Title

Prognosis and related risk factors of patients with scarred uterus complicated with central placenta previa

Journal

Ginekologia Polska

Issue

Vol 90, No 4 (2019)

Pages

185-188

Published online

2019-04-29

DOI

10.5603/GP.2019.0033

Pubmed

31059110

Bibliographic record

Ginekol Pol 2019;90(4):185-188.

Keywords

scarred uterus
central placenta previa
risk factor

Authors

Juntao Zheng
Shanshan Liu
Jianqin Xing

References (15)
  1. Panici PB, Anceschi M, Borgia ML, et al. Fetal Maternal Risk Group. Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta. J Matern Fetal Neonatal Med. 2012; 25(12): 2512–2516.
  2. M M, A V, Gn G, et al. Association of Placenta Previa with a History of Previous Cesarian Deliveries and Indications for a Possible Role of a Genetic Component. Balkan J Med Genet. 2017; 20(2): 5–10.
  3. Sinha P, Mishra M. Caesarean scar pregnancy: a precursor of placenta percreta/accreta. J Obstet Gynaecol. 2012; 32(7): 621–623.
  4. Mehrabadi A, Hutcheon JA, Liu S, et al. Maternal Health Study Group of Canadian Perinatal Surveillance System (Public Health Agency of Canada). Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. Obstet Gynecol. 2015; 125(4): 814–821.
  5. Kumru P, Demirci O, Erdogdu E, et al. The Bakri balloon for the management of postpartum hemorrhage in cases with placenta previa. Eur J Obstet Gynecol Reprod Biol. 2013; 167(2): 167–170.
  6. Koyano M, Hasegawa J, Arakaki T, et al. Successful treatment of placenta previa totalis using the combination of a two-stage cesarean operation and uterine arteries embolization in a hybrid operating room. Case Reports in Perinatal Medicine. 2016; 5(1).
  7. Higgins MF, Monteith C, Foley M, et al. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 2013; 171(1): 54–56.
  8. Betran AP, Torloni MR, Zhang JJ, et al. WHO Working Group on Caesarean Section. WHO Statement on Caesarean Section Rates. BJOG. 2016; 123(5): 667–670.
  9. Xue L, Zhang GY. Influence of Uterine Scar Combined with Central Placenta Previa on Delivery Outcome and the Mother and Baby. Med Recapitul. 2015; 21: 3605–3606.
  10. Liu J, Xie XQ. Influence of different attachment sites of placenta previa on maternal and child outcomes of re-pregnancy after cesarean section. China Mod Med. 2014; 21: 31–32.
  11. Zhang XQ, Cheng XW, Wang LF, et al. Perioperative nursing care of patients with dangerous placenta previa treated with uterine balloon. Chin J Nursing. 2016; 51: 1317–1319.
  12. Kollmann M, Gaulhofer J, Lang U, et al. Placenta praevia: incidence, risk factors and outcome. J Matern Fetal Neonatal Med. 2016; 29(9): 1395–1398.
  13. Mastrolia SA, Baumfeld Y, Loverro G, et al. Placenta previa associated with severe bleeding leading to hospitalization and delivery: a retrospective population-based cohort study. J Matern Fetal Neonatal Med. 2016; 29(21): 3467–3471.
  14. Wang W, Guo Y, Zhang D, et al. The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys. Sci Rep. 2015; 5: 13546.
  15. Yousefzadeh S, Esmaeili Darmiyan M, Asadi Younesi M, et al. Esmaeili Darmiyan M, Asadi Younesi M, The Effect of a Training Program During Pregnancy on the Attitude and Intention of Nulliparous Women to Choose the Delivery Mode. J Midwifery Reprod Health. 2016; 4(3): 704–711.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl